As the cannabis industry navigates a complex landscape of evolving regulations and fluctuating market sentiment, MarketBeat has identified a select group of companies poised for increased investor attention. On November 23rd, 2025, MarketBeat’s stock screener tool highlighted seven cannabis stocks demonstrating the highest recent dollar trading volume, signaling significant market interest and liquidity.
These featured companies span various segments of the burgeoning cannabis ecosystem, from cultivation and processing to retail operations and ancillary services, including the provision of specialized equipment. The list includes prominent names such as Canopy Growth (CGC), Tilray Brands (TLRY), Cronos Group (CRON), Aurora Cannabis (ACB), SNDL (SNDL), WM Technology (MAPS), and High Tide (HITI).
MarketBeat’s November 23rd Watchlist
MarketBeat’s methodology focuses on stocks exhibiting strong trading activity, suggesting that these companies are currently trending among investors. The selection underscores the sector’s inherent potential for growth alongside its pronounced volatility and sensitivity to legal and market changes.
Among the highlighted companies, Canopy Growth has recently shown positive momentum. The company reported its fiscal second quarter results on November 7th, surpassing earnings per share and revenue expectations, with revenue reaching $83 million against a forecasted $71.82 million. Further strengthening its position, Canopy Growth expanded its medical cannabis line in Australia on November 18th. The stock was observed trading up by 3.15% on November 24th, reflecting renewed investor optimism and operational improvements that led to an analyst upgrade to ‘Hold’ from ‘Sell’ on November 10th. Canopy Growth’s business segments encompass Canada Cannabis, International Markets Cannabis, and its renowned vaporization device subsidiary, Storz & Bickel.
Tilray Brands, another key player, presents a more mixed picture. While the company is involved in the research, cultivation, processing, and global distribution of medical cannabis, its stock has experienced significant price declines, falling 39% in the past month and 36% over the last year. Despite a lower price-to-sales ratio compared to industry peers, Tilray’s future prospects remain closely tied to potential U.S. federal legalization, a factor that has historically driven its stock performance. The company recently held its annual stockholders meeting on November 18th, where key proposals were approved, though a significant governance changes proposal did not pass. Analysts maintain a mixed ‘Hold’ consensus for TLRY stock, with an average target price of $2.00.
Akanda Corp, also noted by MarketBeat, shows considerable technical divergence. As of November 24th, its moving average trends lean bearish, with short-selling activity increasing. While the stock saw an 8.82% gain on November 24th, it has fallen on nine of the last ten days, indicating ongoing price volatility. Forecasts for Akanda’s stock vary widely, with some projecting substantial long-term growth while technical indicators suggest caution.
Industry Dynamics and Investment Considerations
Cannabis stocks are inherently characterized by high risk and volatility, driven by a complex interplay of regulatory shifts, capital market dynamics, and investor sentiment cycles. The U.S. market, in particular, continues to grapple with federal illegality despite widespread state-level legalization, creating persistent uncertainty around banking, taxation, and interstate commerce.
Recent news also highlights significant regulatory developments impacting the broader sector. A new federal law, passed recently, imposes a one-year deadline to ban most consumable hemp products, including THC-infused beverages, which have seen rapid growth. This legislation, set to take effect around November 2026, introduces further complexity for companies operating in or adjacent to the cannabis space.
Despite these challenges, the Canadian cannabis market continues to show resilience. September 2025 retail sales, while slightly down month-over-month, were up 6.6% year-over-year, with legal sales steadily replacing the illicit market. Companies are increasingly focusing on profitability, cost control, and high-margin opportunities like medical exports and branded products.
Conclusion
As investors assess the cannabis market for opportunities in late 2025, the stocks highlighted by MarketBeat represent key areas of focus. Canopy Growth’s recent financial improvements and strategic expansions, coupled with Tilray Brands’ efforts to navigate its challenges, offer different investment profiles. Akanda Corp’s volatile price action underscores the sector’s inherent unpredictability. For any investor, thorough due diligence, an understanding of the significant risks, and careful consideration of the ever-changing regulatory landscape are paramount when engaging with this dynamic and trending industry.
